496dkk
-2,7 %
Date:2025-10-10Time:18:00:00Latest report:Q2-2025List:SpotlightTicker:CURAS
Market Cap:223 mdkkEnterprise Value:208 mdkkNet Sales:- mdkkEarnings:-43,9 mdkkEmployees:0ISIN:DK0061295797

Ratios

10-year key figure history for Curasight turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Curasight with index and moving average MA50 and MA200.

Stockprice:4,96
MA50:4,65
MA200:5,59
Price/MA200:-11,2 %
RSI (14):51,5
Price/MA50:6,7 %

Description

Curasight operates in the pharmaceutical industry. The company specializes in the development of technological products. The product portfolio has its main focus in the development of innovative technologies for the diagnosis and treatment of cancer based on targeted PET imaging and radionuclide therapy. The business is operated with the largest presence in Scandinavia. Curasight is headquartered in Copenhagen.

Pharmaceuticals